Both are GSH delivery formats in which the final active ingredient is reduced glutathione
Supplements are not regulated by the FDA in the same way as prescription medications, and individual results may vary
Heres what we do know from the few human reports available, and why they offer limited reassurance: Phase I trial (unpublished): In 2015, a formal Phase I trial on 42 healthy volunteers was initiated to assess BPC-157s safety and pharmacokinetics
Mammalian Proapoptotic Factor ChaC1 and Its Homologues Function as -Glutamyl Cyclotransferases Acting Specifically on Glutathione
Considered safe: When used appropriately, NAC and glutathione are generally well-tolerated, with minimal side effects
Regular physician follow-ups to assess cognitive improvements, monitor safety parameters, adjust protocols as needed, and ensure optimal therapeutic outcomes for brain health